中国医学前沿杂志(电子版)
中國醫學前沿雜誌(電子版)
중국의학전연잡지(전자판)
CHINESE JOURNAL OF THE FRONTIERS OF MEDICAL SCIENCE(ELECTRONIC VERSION)
2014年
4期
22-25
,共4页
刘小琛%冯雁%张力图%梁新强%李科志
劉小琛%馮雁%張力圖%樑新彊%李科誌
류소침%풍안%장력도%량신강%리과지
食管癌%淋巴细胞%流式细胞术
食管癌%淋巴細胞%流式細胞術
식관암%림파세포%류식세포술
Esophageal cancer%Lymphocyte%Flow cytometry
目的探讨食管癌患者治疗前后外周血淋巴细胞的变化及其与预后的关系。方法采用流式细胞术(FCM)检测53例食管癌患者治疗前后外周血淋巴细胞水平。结果食管癌患者治疗后与治疗前比较,CD3+细胞水平升高,差异有显著性,其余指标差异无显著性;Ⅲ~Ⅳ期和Ⅰ~Ⅱ期的患者比较,治疗前CD4+和CD3+细胞水平较低,差异有显著性,其余指标及治疗后各项指标差异均无显著性;有淋巴结转移和无淋巴结转移的患者比较,治疗前自然杀伤细胞(NK)水平较高,差异有显著性,其余指标及治疗后各项指标差异均无显著性;有复发或转移与无复发或转移的患者比较,治疗前CD4+细胞水平较低,CD8+、NK、CD19+细胞水平较高,差异有显著性,治疗后CD4+细胞水平较低,CD8+、NK、CD19+细胞水平较高,差异有显著性,CD3+细胞水平差异无显著性。结论CD4+细胞水平减低伴随CD8+、NK和CD19+细胞水平显著升高,可能是评估食管癌治疗后复发或迅速恶化的标志。
目的探討食管癌患者治療前後外週血淋巴細胞的變化及其與預後的關繫。方法採用流式細胞術(FCM)檢測53例食管癌患者治療前後外週血淋巴細胞水平。結果食管癌患者治療後與治療前比較,CD3+細胞水平升高,差異有顯著性,其餘指標差異無顯著性;Ⅲ~Ⅳ期和Ⅰ~Ⅱ期的患者比較,治療前CD4+和CD3+細胞水平較低,差異有顯著性,其餘指標及治療後各項指標差異均無顯著性;有淋巴結轉移和無淋巴結轉移的患者比較,治療前自然殺傷細胞(NK)水平較高,差異有顯著性,其餘指標及治療後各項指標差異均無顯著性;有複髮或轉移與無複髮或轉移的患者比較,治療前CD4+細胞水平較低,CD8+、NK、CD19+細胞水平較高,差異有顯著性,治療後CD4+細胞水平較低,CD8+、NK、CD19+細胞水平較高,差異有顯著性,CD3+細胞水平差異無顯著性。結論CD4+細胞水平減低伴隨CD8+、NK和CD19+細胞水平顯著升高,可能是評估食管癌治療後複髮或迅速噁化的標誌。
목적탐토식관암환자치료전후외주혈림파세포적변화급기여예후적관계。방법채용류식세포술(FCM)검측53례식관암환자치료전후외주혈림파세포수평。결과식관암환자치료후여치료전비교,CD3+세포수평승고,차이유현저성,기여지표차이무현저성;Ⅲ~Ⅳ기화Ⅰ~Ⅱ기적환자비교,치료전CD4+화CD3+세포수평교저,차이유현저성,기여지표급치료후각항지표차이균무현저성;유림파결전이화무림파결전이적환자비교,치료전자연살상세포(NK)수평교고,차이유현저성,기여지표급치료후각항지표차이균무현저성;유복발혹전이여무복발혹전이적환자비교,치료전CD4+세포수평교저,CD8+、NK、CD19+세포수평교고,차이유현저성,치료후CD4+세포수평교저,CD8+、NK、CD19+세포수평교고,차이유현저성,CD3+세포수평차이무현저성。결론CD4+세포수평감저반수CD8+、NK화CD19+세포수평현저승고,가능시평고식관암치료후복발혹신속악화적표지。
Objective To explore the change of peripheral blood lymphocytes in patients with esophageal cancer before and after the treatment, and its relationship with the prognosis. Methods Flow cytometry (FCM) was used to detect the levels of peripheral blood lymphocytes before and after the treatment in patients with esophageal cancer. Results Compared the patients after treatment with those before treatment, the level of CD3+cells was elevated, the difference was statistically signiifcant, there was no statistically signiifcant difference among the rest of the indicators;Compared the patients with stageⅢ~Ⅳ with those with stageⅠ~Ⅱ, the levels of CD4+and CD3+cells were depressed in patients before treatment, the difference was statistically signiifcant, the rest of the indicators and the difference between each index after treatment had no statistical signiifcance;Compared the patients with lymph node metastasis with those without lymph node metastasis, the level of NK was elevated inpatients before treatment, the difference was statistically signiifcant, the rest of the indicators and the difference between each index after treatment had no statistical signiifcance;Compared the patients with recurrence or metastasis with those without recurrence or metastasis, the level of CD4+cells was depressed in patients before and after the treatment ,and the levels of CD8+, NK cell, CD19+cells levels were elevated, the difference was statistically signiifcant, there was no statistically signiifcant difference of CD3+cells. Conclusion The reducing of CD4+ cells along with the increasing of CD8+ , NK and CD19+ cells may be a sign of assessing recurrence and deteriorating rapidly in patients with esophageal cancer after treatment.